SCHEMBL18803565

SCHEMBL18803565

Brc1ccc(-c2nc3ccccc3c3oc4ccccc4c23)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ RXFP1 Q9HBX9 1/20 0.47
▸ CYP1B1 Q16678 3/20 0.41
▸ CYP1A1 P04798 2/20 0.41
▸ TNKS O95271 2/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ CSF1R P07333 1/20 0.41
▸ PDGFRB P09619 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ KIT P10721 1/20 0.41
▸ FLT3 P36888 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ HDAC6 Q9UBN7 1/20 0.41
▸ TNKS2 Q9H2K2 1/20 0.40
▸ AKR1B10 O60218 1/20 0.39
▸ ABCG2 Q9UNQ0 1/20 0.39
▸ MAOB P27338 1/20 0.39
▸ GRM2 Q14416 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22274043 0.90 MAPT (0.50) MEN1CSF1RPDGFRBMAPTKIT
SCHEMBL18803665 0.89 NPC1 (0.47) NPC1RAB9ARXFP1CYP1B1CYP1A1
SCHEMBL22274046 0.87 GABRP (0.46) NPC1RAB9ARXFP1MEN1CSF1R
SCHEMBL18805455 0.87 MAPT (0.38) NPC1RAB9ARXFP1TNKSCYP1A2
SCHEMBL18803735 0.86 KMT2A (0.49) CYP1A2MEN1CSF1RPDGFRBMAPT
SCHEMBL18847916 0.85 NPC1 (0.44) NPC1RAB9ARXFP1CYP1B1CYP1A1
SCHEMBL18804189 0.85 GABRP (0.46) NPC1RAB9ACYP1A2MEN1CSF1R
SCHEMBL19627963 0.85 TNKS (0.39) NPC1RAB9ARXFP1CYP1B1CYP1A1
SCHEMBL18804052 0.84 KMT2A (0.48) CYP1A2MEN1CSF1RPDGFRBMAPT
SCHEMBL19627960 0.84 TNKS (0.39) NPC1RAB9ARXFP1TNKSCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3162806-B1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME LT MATERIALS CO LTD (KR) 2023-08-23 — — EP disclosed
WO-2020153758-A1 COMPOSITION, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE 엘티소재주식회사 2020-07-30 — — WO disclosed
US-20170141325-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME HEESUNG MATERIAL LTD. (KR) 2017-05-18 — — US disclosed
US-20170141325-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME HEESUNG MATERIAL LTD. (KR) 2017-05-18 — — US disclosed
EP-3162806-A2 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME Heesung Material Ltd. (KR) 2017-05-03 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170141325-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME CRY1, CRY2, CYBA NPC1 4299/4885RAB9A 3913/4885RXFP1 4874/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback